BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Biopharma money raised: Jan. 1-April 16, 2026

April 17, 2026
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Money raised by biopharma

April 17, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Regulatory actions for April 17, 2026

April 17, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adimab, Aicuris, Bavarian Nordic, Cumberland, Fertilai, Grifols, Mabwell, Medera, Royal Philips, Savara, Surgentec, Waiv.
Read More

Other news to note for April 17, 2026

April 17, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aligos, Amgen, Amoytop, Astellas, Caredx, Cathether, Daiichi, Eurobio, Interna, Johnson & Johnson, Mabwell, Meiragtx, Sanofi, Vir.
Read More

In the clinic for April 17, 2026

April 17, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Acerand, Axena, Boehringer Ingelheim, Bold, Eli Lilly, Freya, Xvivo.
Read More

Financings for April 17, 2026

April 17, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Achieve Life Sciences, Acurx, Adlai, Meiragtx, Onward, Pamdx.
Read More

Appointments and advancements for April 17, 2026

April 17, 2026
New hires and promotions in the biopharma and med-tech industries, including: Achieve Life Sciences, Aktis, Araceli, Assureckd, Cubit, Envoy, Eton, Greywolf, Harbour, Helus, Juvisé, Neutrolis, Prime, Xilo.
Read More

Today's news in brief

April 17, 2026
BioWorld briefs for April 17, 2026.
Read More

Regulatory actions for April 16, 2026

April 16, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airs, Aligos, AOP, Arbutus, ARS, Cala, C-mo, Dogwood, Immutep, Leadiant, Leo, Northstar, Opna, Partner, Reach Surgical, Waters, Xspray.
Read More

Other news to note for April 16, 2026

April 16, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 35Pharma, Accurkardia, Acuitas, Adia, Cepheid, Circio, Daiichi, GSK, Olea, Ovation, Oxford Nanopore, Oxipit, Precisionlife, QT Imaging, Robocath, Sectra, Specialized Medical, Stereotaxis, Wayfinder.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 1782 1783 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing